This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Clinical Laserthermia Systems Zukünftiges Wachstum

We currently don't have sufficient analyst coverage to forecast growth and revenue for Clinical Laserthermia Systems.

56.9%

Wachstumsrate der Gewinne

50.0%

EPS-Wachstumsrate

Medical Equipment Gewinnwachstum	27.0%
Wachstumsrate der Einnahmen	56.5%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Low
Zuletzt aktualisiert	24 Feb 2023

Keine Aktualisierungen

Keine Aktualisierungen

Gewinn- und Umsatzwachstumsprognosen

OM:CLS UR B - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (SEK Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2025	115	-2	N/A	N/A	1
12/31/2024	44	-45	-48	-45	1
12/31/2023	17	-70	-70	-67	1
3/31/2023	6	-78	-71	-68	N/A
12/31/2022	6	-71	-69	-68	N/A
9/30/2022	3	-81	-81	-81	N/A
6/30/2022	2	-63	-66	-66	N/A
3/31/2022	2	-68	-71	-71	N/A
12/31/2021	2	-64	-67	-66	N/A
9/30/2021	1	-60	-63	-63	N/A
6/30/2021	2	-57	-55	-55	N/A
3/31/2021	2	-47	-41	-41	N/A
12/31/2020	1	-58	-56	-55	N/A
9/30/2020	1	-58	-54	-53	N/A
6/30/2020	2	-57	-54	-54	N/A
3/31/2020	6	-54	-52	-52	N/A
12/31/2019	6	-43	-39	-39	N/A
9/30/2019	6	-38	-37	-36	N/A
6/30/2019	5	-37	-35	-34	N/A
3/31/2019	1	-41	-44	-43	N/A
12/31/2018	8	-33	-41	-39	N/A
9/30/2018	10	-28	-33	-31	N/A
6/30/2018	11	-24	-33	-31	N/A
3/31/2018	12	-15	-29	-24	N/A
12/31/2017	8	-21	-29	-24	N/A
9/30/2017	8	-22	-34	-29	N/A
6/30/2017	8	-26	-28	-24	N/A
3/31/2017	6	-27	-24	-23	N/A
12/31/2016	4	-27	N/A	-20	N/A
9/30/2016	1	-27	N/A	-19	N/A
6/30/2016	0	-23	N/A	-22	N/A
3/31/2016	0	-20	N/A	-17	N/A
12/31/2015	N/A	-17	N/A	-19	N/A
9/30/2015	0	-21	N/A	-21	N/A
6/30/2015	0	-20	N/A	-20	N/A
3/31/2015	0	-20	N/A	-19	N/A
12/31/2014	N/A	-18	N/A	-16	N/A
9/30/2014	0	-16	N/A	-18	N/A
6/30/2014	N/A	-16	N/A	-18	N/A
3/31/2014	N/A	-17	N/A	-17	N/A
12/31/2013	N/A	-18	N/A	-18	N/A
9/30/2013	0	-16	N/A	-13	N/A
6/30/2013	N/A	-15	N/A	-12	N/A
3/31/2013	0	-13	N/A	-11	N/A
12/31/2012	N/A	-13	N/A	-12	N/A
9/30/2012	0	-11	N/A	-10	N/A

Einkommen vs. Sparrate: CLS UR B is forecast to remain unprofitable over the next 3 years.

Ertrag vs. Markt: CLS UR B is forecast to remain unprofitable over the next 3 years.

Hohe Wachstumserträge: CLS UR B is forecast to remain unprofitable over the next 3 years.

Einnahmen vs. Markt: CLS UR B's revenue (56.5% per year) is forecast to grow faster than the Swedish market (5.5% per year).

Hohe Wachstumseinnahmen: CLS UR B's revenue (56.5% per year) is forecast to grow faster than 20% per year.

Künftige Eigenkapitalrendite: Insufficient data to determine if CLS UR B's Return on Equity is forecast to be high in 3 years time